HOME >> MEDICINE >> NEWS
Timely antiretroviral therapy essential for best prognosis in people with HIV-1 infection

Authors of an international study in this week's issue of THE LANCET highlight how timely treatment with highly-active antiretroviral therapy (HAART) can substantially improve the three-year prognosis for people with HIV-1 infection.

HAART became widespread in more-developed countries in 1996. However, there is insufficient data from individual studies to estimate the prognosis of people with HIV-1 infection starting HAART. The ART Cohort Collaboration, led by Matthias Egger from the University of Bern, Switzerland, was established to fill this knowledge gap.

The investigators analysed data on over 12,000 adult patients from 13 prospective studies from Europe and North America. The patients had not received antiretroviral therapy previously and started HAART with a combination of at least three drugs. 870 patients developed a new AIDS event and 344 patients died.

More advanced disease-as demonstrated by a low CD4 white blood cell count at the beginning of HAART-was strongly associated with the probability of progression to AIDS or death. Compared with patients starting HAART with less than 50 CD4 cells per microlitre, patients with a CD4 count between 50 and 99 per microlitre had around a 25% relative reduction in risk of AIDS or death; those with counts between 100 and 199 had around a 50% relative risk reduction, whereas patients with initial CD4 cell counts above 200 per microlitre had a relative risk reduction of around 80%. A blood concentration of the HIV-1 virus above 100,000 copies per millilitre at the start of therapy was also associated with a higher probability of progression to AIDS or death. Other independent predictors of poorer outcome were advanced age, HIV-1 infection through injection drug use, and a previous diagnosis of AIDS. Overall, the probability of progression to AIDS or death at 3 years ranged from 3% for patients in the lowest risk category for all prognostic variables, to 50% for patients at the highest risk.
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
11-Jul-2002


Page: 1 2

Related medicine news :

1. Timely surgery dramatically reduces stroke risk for people with carotid stenosis
2. Study examines lessons learned at Africas first public antiretroviral treatment clinic
3. Archival virus still necessitates life-long antiretroviral therapy
4. Allocating antiretrovirals
5. Substantial survival increase after highly active antiretroviral therapy for HIV-1 infection
6. Alcohol consumption increases HIV disease progression of patients receiving antiretroviral therapy
7. Guidelines issued for metabolic complications related to HIV & antiretrovirals
8. UCLA AIDS Institute scientists show antiretroviral drugs can eradicate AIDS epidemic
9. Eficiency, feasibility of antiretroviral therapy in Africa demonstrated in IRD-coordinated surveys
10. Exposure to hepatitis C has no effect on antiretroviral treatment outcomes in HIV patients
11. Successful implementation of pilot study for HIV antiretroviral therapy in Uganda

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2019)... ... 08, 2019 , ... Intelligent.com, a trusted resource for online ... Programs for 2020. The comprehensive research guide is based on an assessment of ... on curriculum quality, graduation rate, reputation, and post-graduate employment. , The 2020 ...
(Date:12/6/2019)... Neb. (PRWEB) , ... December 06, 2019 , ... ... and recruiting, has been recognized for excellence in employee learning. The Omaha-based company ... which ranks organizations with the most successful employer-sponsored training and development programs worldwide. ...
(Date:12/6/2019)... ... December 06, 2019 , ... Connecticut is ... and excellence in patient care. On December 12th, Hartford Business Journal will recognize ... Health Care Heroes Awards at the Hartford Marriott. , “We are fortunate to ...
(Date:12/6/2019)... ... ... Allegheny Health Network (AHN) has named Kymberly Gyure, MD, Chair of the AHN Pathology ... previously served as AHN’s Vice Chair of Pathology and Laboratory Medicine, and Director of ... of the pathology faculty at Drexel University College of Medicine. , Dr. Gyure ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... compliance solution for the Wyoming Medical Society. Compliancy Group is dedicated to educating ... have an obligation to adhere to the standards set forth by the Health ...
Breaking Medicine News(10 mins):
(Date:12/9/2019)... ... December 09, 2019 , ... American Pharmaceutical Review, the leading ... released its documentary on " Making Data Work: Leveraging Data for Better Outcomes. ... currently using data to produce products, and how they can leverage the ever-increasing ...
(Date:12/8/2019)... ... December 07, 2019 , ... ... affairs, regulatory, and technology-enabled solutions, announced that MAIA Pharmaceuticals, Inc. (MAIA), a specialty ... has chosen Soterius and its partners in Europe, to support their regulatory strategy ...
(Date:12/6/2019)... ... December 06, 2019 , ... In ... this month, Kenall is introducing the CSEDOIC luminaire series. CSEDOIC fixtures are designed ... requires the unpacking of hazardous drugs (HDs) and HD-active pharmaceutical ingredients from the ...
Breaking Medicine Technology:
Cached News: